Baba, T., Sato-Matsushita, M., Kanamoto, A., Itoh, A., Oyaizu, N., Inoue, Y., . . . Tahara, H. (2010). Phase I clinical trial of the vaccination for the patients with metastatic melanoma using gp100-derived epitope peptide restricted to HLA-A*2402. BioMed Central.

Baba, Toshiyuki, Marimo Sato-Matsushita, Akira Kanamoto, Akihiko Itoh, Naoki Oyaizu, Yusuke Inoue, Yutaka Kawakami, e Hideaki Tahara. Phase I Clinical Trial of the Vaccination for the Patients With Metastatic Melanoma Using Gp100-derived Epitope Peptide Restricted to HLA-A*2402. BioMed Central, 2010.

Baba, Toshiyuki, et al. Phase I Clinical Trial of the Vaccination for the Patients With Metastatic Melanoma Using Gp100-derived Epitope Peptide Restricted to HLA-A*2402. BioMed Central, 2010.